Mexico Boasts second-Lowest Unemployment Rate Globally
President Claudia Sheinbaum Pardo announced that Mexico is poised to end the year with one of the world’s lowest unemployment rates, at 2.7%.This figure places Mexico second globally, trailing only Japan with a rate of 2.6%.
“We close this year as the second country with the least unemployment in the world. The conversion delivers results,” Sheinbaum stated on X, accompanied by an official comparative graph released by the Mexican government.
The data, compiled on December 24th from datamacro.expansion.com/paro, showcases unemployment rates across 14 countries.
Following Mexico are germany (3.8%), the Netherlands (4%), Australia (4.3%), the United States (4.6%), and ireland (4.9%). Austria (5.8%), Italy (6%), Belgium (6.4%), France (7.7%),Sweden (9.1%), Finland (10.3%), and Spain (10.5%) complete the comparison.
It’s important to note that unemployment figures for Mexico, the Netherlands, Australia, the USA, Ireland, and Sweden reflect data up to November of this year. Data for Japan, Germany, Austria, Italy, Belgium, France, Finland, and Spain are current as of October.
!Mexico Unemployment Rate Comparison
Worth a look
- Philippines Adopts 2026-2030 Forest Carbon Roadmap for Climate Finance
- Naples Airport Tarmac Dog Adopted by Local Family
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)